VINC Vincera Pharma, Inc.

Vincera Pharma, Inc. is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.

$14.11
As of 10/18/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/27/2020
Outstanding shares:  17,521,075
Average volume:  80,763
Market cap:   $258,435,856
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92731L106
ISIN:        US92731L1061
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.63
PS ratio:   0.00
Return on equity:   -19.09%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy